MTF2 and acute myeloid leukemia: We recently showed that MTF2 regulates chemotherapeutic response in acute myeloid leukemia (AML), and since the levels of MTF2 and H3K27me3 are correlated with response to induction chemotherapy, they may be useful biomarkers to prospectively identify patients with chemoresistant disease at diagnosis [13,14].